Also known as
1‑Methyl‑2‑androstene‑3‑one
The name 1-Methyl-2-androstene-3-one is a structural designation for the anabolic androgenic steroid stanozolol. This oral-only compound is stocked by SynthesisGear in two distinct product listings. Users report that it is used to support lean mass gains and strength, with a typical starting dose of 50 mg per day. Athletes typically run these protocols for 6 to 8 weeks. Because this is a 17-alpha-alkylated compound, careful attention to liver function and blood work is required during use.
Chemical Identity and Structure
The term 1-Methyl-2-androstene-3-one refers specifically to the androgenic steroid framework of stanozolol. It is a 17-alpha-alkylated derivative, meaning it has been modified to resist rapid hepatic degradation. This structural feature dictates its oral bioavailability and necessitates monitoring for potential hepatotoxicity. No other esters or metabolic variants are present in these formulations.
Product Options and Sourcing
SynthesisGear currently offers two separate stanozolol products: one from Prime and one from Magnus. Both contain 10 mg per tablet in a 100-tablet pack. Buyers should weigh the manufacturer, as there are no differences in dose or formulation between them. The shop ships exclusively within the EU, and support is available via email for any product inquiries.
Questions & answers
Is 1-Methyl-2-androstene-3-one an oral steroid?
Yes, it is the structural name for stanozolol, which is administered orally only. No injectable forms exist.
What are the typical starting doses of stanozolol?
Commonly cited protocols start at 50 mg per day, with some users increasing to 100 mg daily based on their goals and tolerance.
Do I need post-cycle therapy after a stanozolol cycle?
Yes, PCT is required following a standard 6-to-8-week cycle to allow the endocrine system to recover.